1. Home
  2. FFIC vs ORGO Comparison

FFIC vs ORGO Comparison

Compare FFIC & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FFIC
  • ORGO
  • Stock Information
  • Founded
  • FFIC 1929
  • ORGO 1985
  • Country
  • FFIC United States
  • ORGO United States
  • Employees
  • FFIC N/A
  • ORGO N/A
  • Industry
  • FFIC Major Banks
  • ORGO Biotechnology: Pharmaceutical Preparations
  • Sector
  • FFIC Finance
  • ORGO Health Care
  • Exchange
  • FFIC Nasdaq
  • ORGO Nasdaq
  • Market Cap
  • FFIC 454.6M
  • ORGO 474.6M
  • IPO Year
  • FFIC 1995
  • ORGO N/A
  • Fundamental
  • Price
  • FFIC $14.26
  • ORGO $3.05
  • Analyst Decision
  • FFIC Hold
  • ORGO Strong Buy
  • Analyst Count
  • FFIC 4
  • ORGO 3
  • Target Price
  • FFIC $15.50
  • ORGO $5.33
  • AVG Volume (30 Days)
  • FFIC 453.4K
  • ORGO 1.1M
  • Earning Date
  • FFIC 01-23-2025
  • ORGO 11-12-2024
  • Dividend Yield
  • FFIC 6.17%
  • ORGO N/A
  • EPS Growth
  • FFIC N/A
  • ORGO N/A
  • EPS
  • FFIC 0.87
  • ORGO N/A
  • Revenue
  • FFIC $193,714,000.00
  • ORGO $455,038,000.00
  • Revenue This Year
  • FFIC N/A
  • ORGO $9.65
  • Revenue Next Year
  • FFIC $14.16
  • ORGO $1.57
  • P/E Ratio
  • FFIC $16.39
  • ORGO N/A
  • Revenue Growth
  • FFIC 4.54
  • ORGO 1.34
  • 52 Week Low
  • FFIC $10.74
  • ORGO $2.17
  • 52 Week High
  • FFIC $18.59
  • ORGO $4.71
  • Technical
  • Relative Strength Index (RSI)
  • FFIC 27.93
  • ORGO 35.65
  • Support Level
  • FFIC $13.97
  • ORGO $3.28
  • Resistance Level
  • FFIC $15.45
  • ORGO $3.68
  • Average True Range (ATR)
  • FFIC 0.59
  • ORGO 0.23
  • MACD
  • FFIC -0.42
  • ORGO -0.10
  • Stochastic Oscillator
  • FFIC 7.30
  • ORGO 0.00

About FFIC Flushing Financial Corporation

Flushing Financial Corp operates as a bank holding company, which is engaged in the provision of banking and financial services. It provides Personal, Business, lending, Government banking, and Card services. Its principal business is attracting retail deposits from the general public and investing those deposits together with funds generated from ongoing operations and borrowings, in originations and purchases of multi-family residential properties, commercial business loans, commercial real estate mortgage loans, construction loans, small business administration loans, and other small business loans.

About ORGO Organogenesis Holdings Inc.

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced wound care, surgical and sports medicine markets. Its product category includes Advanced Wound Care and Surgical and Sports Medicine. It has single operating segment which has regenerative medicine. The company generates maximum revenue from Advanced Wound Care products. Some of its products include PuraPly Antimicrobial, Affinity, NuShield, Apligraf, Dermagraft and others.

Share on Social Networks: